Table 3 Comparison of SOX2 expression at diagnosis, remission, and relapse among leukemic patients
From: Significance of OCT3/4 and SOX2 antigens expression by leukemic blast cells in adult acute leukemia
Parameter | ALL (n = 38) | AML (n =4 2 ) |
|---|---|---|
Median (min–max) | Median (min–max) | |
SOX2 expression (%) at diagnosis | 16.3% (0.3–71.6) | 25.7% (0.1–81.8) |
SOX2 expression (%) at remission | 1.0% (0.20–9.16) | 1.32% (0.03–14.0) |
SOX2 expression (%) at relapse | 1.6 % (0.3–67.8) | 24.9 % (2.61–87.0) |
P1 | < 0.001 | < 0.001 |
P2 | 0.066 | 0.386 |
P3 | 0.008 | 0.005 |